Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+immunologic neighborhoods containing NK cells, T cells and macrophages

被引:2
|
作者
Nersesian, Sarah [1 ,2 ]
Arseneau, Riley J. [2 ,3 ]
Mejia, Jorge P. [1 ,2 ]
Lee, Stacey N. [1 ,2 ]
Westhaver, Lauren P. [3 ]
Griffiths, Nigel W. [3 ]
Grantham, Stephanie R. [2 ]
Meunier, Liliane [4 ,5 ]
Communal, Laudine [4 ,5 ]
Mukherjee, Avik [6 ]
Mes-Masson, Anne-Marie [4 ,7 ]
Arnason, Thomas [3 ,8 ]
Nelson, Brad H. [9 ,10 ,11 ]
Boudreau, Jeanette E. [1 ,2 ,3 ]
机构
[1] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada
[2] Beatrice Hunter Canc Res Inst, Halifax, NS, Canada
[3] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada
[4] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada
[5] Inst Canc Montreal, Montreal, PQ, Canada
[6] Akoya Biosci, Menlo Pk, CA USA
[7] Univ Montreal, Dept Med, Montreal, PQ, Canada
[8] QEII Hlth Sci Ctr, Dept Pathol & Lab Med, Nova Scotia Hlth Cent Zone, Halifax, NS, Canada
[9] British Columbia Canc Res Inst, Deeley Res Ctr, Victoria, BC, Canada
[10] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada
[11] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 14卷
基金
加拿大健康研究院;
关键词
natural killer (NK) cell; ovarian cancer; high grade serous cancer; spatial biology; CD16A; NATURAL-KILLER-CELLS; ANTITUMOR-ACTIVITY; IN-VIVO; LYMPHOCYTES; ENGAGER; SAFETY;
D O I
10.3389/fimmu.2023.1307873
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background For patients with high grade serous carcinoma of the ovary (HGSC), survival rates have remained static for the last half century. Despite the presence of tumor mutations and infiltration of immune cells, existing immunotherapies have achieved little success against HGSC. These observations highlight a gap in the understanding of how the immune system functions and interacts within HGSC tumors.Methods We analyzed duplicate core samples from 939 patients with HGSC to understand patterns of immune cell infiltration, localization, and associations with clinical features. We used high-parameter immunohistochemical/Opal multiplex, digital pathology, computational biology, and multivariate analysis to identify immune cell subsets and their associations with HGSC tumors.Results We defined six patterns of cellular infiltration by spatially restricted unsupervised clustering of cell subsets. Each pattern was represented to some extent in most patient samples, but their specific distributions differed. Overall (OS) and progression-free survival (PFS) corresponded with higher infiltration of CD16a+ cells, and their co-localization with macrophages, T cells, NK cells, in one of six cellular neighborhoods that we defined with our spatial assessment.Conclusions Immune cell neighborhoods containing CD16a+ cells are associated with improved OS and PFS for patients with HGSC. Patterns of immunologic neighborhoods differentiate patient outcomes, and could inform future, more precise approaches to treatment.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Anticancer effects of the gold complex auranofin on high-grade serous ovarian cancer cells
    Abdalbari, Farah H.
    Goyeneche, Alicia A.
    Jaramillo, Elvis M.
    Sabri, Siham
    Telleria, Carlos M.
    CANCER RESEARCH, 2022, 82 (12)
  • [32] Isolation and Characterization of Cancer Stem Cells from High-Grade Serous Ovarian Carcinomas
    He, Qi-zhi
    Luo, Xue-zhen
    Wang, Kai
    Zhou, Qian
    Ao, Hong
    Yang, Yan
    Li, Shu-xia
    Li, Ying
    Zhu, Hui-ting
    Duan, Tony
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2014, 33 (01) : 173 - 184
  • [33] Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells
    Reavis, Hunter D.
    Gysler, Stefan M.
    McKenney, Grace B.
    Knarr, Matthew
    Lusk, Hannah J.
    Rawat, Priyanka
    Rendulich, Hannah S.
    Mitchell, Marilyn A.
    Berger, Dara S.
    Moon, Jamie S.
    Ryu, Suyeon
    Mainigi, Monica
    Iwanicki, Marcin P.
    Hoon, Dave S.
    Sanchez, Laura M.
    Drapkin, Ronny
    JCI INSIGHT, 2024, 9 (05)
  • [34] Exploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian Cancer
    Coan, Michela
    Vinciguerra, Gian Luca Rampioni
    Cesaratto, Laura
    Gardenal, Emanuela
    Bianchet, Riccardo
    Dassi, Erik
    Vecchione, Andrea
    Baldassarre, Gustavo
    Spizzo, Riccardo
    Nicoloso, Milena Sabrina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (09)
  • [35] VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer
    Liju Zong
    Yuncan Zhou
    Ming Zhang
    Jie Chen
    Yang Xiang
    Cancer Immunology, Immunotherapy, 2020, 69 : 33 - 42
  • [36] VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer
    Zong, Liju
    Zhou, Yuncan
    Zhang, Ming
    Chen, Jie
    Xiang, Yang
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (01) : 33 - 42
  • [37] Expression of inflammatory biomarkers is associated with prognosis in patients with high-grade serous ovarian cancer
    Brzezinska, Bogna
    Mysona, David
    Richardson, Katherine
    Purohit, Sharad
    Suhner, Jessa
    Vaz, Jennifer
    Johnson, Marian
    Higgins, Robert
    Rungruang, Bunja
    Ghamande, Sharad
    McIndoe, Richard
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S303 - S304
  • [38] Disparities in treatment modalities and survival among older patients with high-grade serous ovarian cancer
    Yan Cai
    Tong Shu
    Hong Zheng
    BMC Women's Health, 24
  • [39] Immune Modeling Analysis Reveals Immunologic Signatures Associated With Improved Outcomes in High Grade Serous Ovarian Cancer
    James, Nicole E.
    Miller, Katherine
    LaFranzo, Natalie
    Lips, Erin
    Woodman, Morgan
    Ou, Joyce
    Ribeiro, Jennifer R.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [40] Predictors of Long-Term Survival among High-Grade Serous Ovarian Cancer Patients
    Clarke, Christina L.
    Kushi, Lawrence H.
    Chubak, Jessica
    Pawloski, Pamala A.
    Bulkley, Joanna E.
    Epstein, Mara M.
    Burnett-Hartman, Andrea N.
    Powell, Bethan
    Pearce, Celeste L.
    Feigelson, Heather Spencer
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (05) : 996 - 999